caseism

Genzymes CSR Dilemma: How to Play its HAND Case Solution & Answer

Genzyme, a global biotechnology company, has launched a program to develop therapies for neglected diseases (eg, malaria, tuberculosis), giving away intellectual property. This case focuses on the decision of the diseases that partnerships and contract management must decide to finance. But the big question is how it developed under the umbrella of the role of social responsibility program Genzyme is part of its overall strategy for competitiveness.
by
Christopher A. Bartlett,
Tarun Khanna,
Prithwiraj Choudhury
Source: HBS Premier Case Collection
23 pages.
Release: Aug 20, 2009. Prod #: 910407-PDF-ENG
Genzyme CSR Dilemma: How the case plays main solution

Share This

LOOK FOR A FREE CASE STUDY SOLUTION

JUST REGISTER NOW AND GET 50% OFF ON EACH CASE STUDY